---
figid: PMC7457231__nihms-1618375-f0006
figlink: pmc/articles/PMC7457231/figure/F6/
number: F6
caption: Cancer cells can traverse the tumor suppressive TGF-β bottleneck by accumulating
  mutations (“X”) that disable the signal transduction pathway. In many gastrointestinal
  cancers, TGF-β receptor and SMAD mutations deeply disable the pathway, and this
  now allows stromal TGF-β to exert pro-tumorigenic effects including immune suppressive
  action on T and NK cells and activation of stromal paracrine loops such as the production
  of tumorigenic cytokines (e.g. IL-11) by cancer-associated fibroblasts (CAF). In
  many other types of cancer, the TGF-β receptors and SMADs remain intact but downstream
  alterations prevent the pathway from triggering tumor suppressive effects. Thus
  corrupted, the TGF-β–SMAD pathway can drive a non-lethal EMT as well the production
  of factors that promote metastatic extravasation, immune evasion, and colonization
  of target tissues.
pmcid: PMC7457231
papertitle: Contextual Determinants of TGF-β Action in Development, Immunity and Cancer.
reftext: Charles J. David, et al. Nat Rev Mol Cell Biol. ;19(7):419-435.
pmc_ranked_result_index: '33198'
pathway_score: 0.5440251
filename: nihms-1618375-f0006.jpg
figtitle: Cancer cells can traverse the tumor suppressive TGFB bottleneck by accumulating
  mutations (“X”) that disable the signal transduction pathway
year: ''
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7457231__nihms-1618375-f0006.html
  '@type': Dataset
  description: Cancer cells can traverse the tumor suppressive TGF-β bottleneck by
    accumulating mutations (“X”) that disable the signal transduction pathway. In
    many gastrointestinal cancers, TGF-β receptor and SMAD mutations deeply disable
    the pathway, and this now allows stromal TGF-β to exert pro-tumorigenic effects
    including immune suppressive action on T and NK cells and activation of stromal
    paracrine loops such as the production of tumorigenic cytokines (e.g. IL-11) by
    cancer-associated fibroblasts (CAF). In many other types of cancer, the TGF-β
    receptors and SMADs remain intact but downstream alterations prevent the pathway
    from triggering tumor suppressive effects. Thus corrupted, the TGF-β–SMAD pathway
    can drive a non-lethal EMT as well the production of factors that promote metastatic
    extravasation, immune evasion, and colonization of target tissues.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFB1
  - TGFB2
  - TGFB3
  - KRAS
  - IL11
  - ZEB1
  - SNAI1
  - ANGPTL4
  - CDKN1A
  - CDKN1B
  - CDKN2D
  - CDKN1C
  - CDKN2A
  - CDKN2B
  - CDKN2C
  - CDKN3
  - CXCR4
  - CAF
  - Metastatic carcinoma
  - growth arrest
genes:
- word: TGF-B-
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGF-B-
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGF-B-
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: KRAS*
  symbol: KRAS
  source: hgnc_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: IL-11
  symbol: IL-11
  source: hgnc_alias_symbol
  hgnc_symbol: IL11
  entrez: '3589'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB1
  entrez: '7040'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB2
  entrez: '7042'
- word: TGF-B
  symbol: TGFB
  source: bioentities_symbol
  hgnc_symbol: TGFB3
  entrez: '7043'
- word: ZEB1
  symbol: ZEB1
  source: hgnc_symbol
  hgnc_symbol: ZEB1
  entrez: '6935'
- word: SNAIL,ZEB1(EMT)
  symbol: SNAIL
  source: hgnc_alias_symbol
  hgnc_symbol: SNAI1
  entrez: '6615'
- word: SNAIL,
  symbol: SNAIL
  source: hgnc_alias_symbol
  hgnc_symbol: SNAI1
  entrez: '6615'
- word: ANGPTL4
  symbol: ANGPTL4
  source: hgnc_symbol
  hgnc_symbol: ANGPTL4
  entrez: '51129'
- word: •ANGPTL4
  symbol: ANGPTL4
  source: hgnc_symbol
  hgnc_symbol: ANGPTL4
  entrez: '51129'
- word: CDKN
  symbol: CDKN
  source: bioentities_symbol
  hgnc_symbol: CDKN1A
  entrez: '1026'
- word: CDKN
  symbol: CDKN
  source: bioentities_symbol
  hgnc_symbol: CDKN1B
  entrez: '1027'
- word: CDKN
  symbol: CDKN
  source: bioentities_symbol
  hgnc_symbol: CDKN2D
  entrez: '1032'
- word: CDKN
  symbol: CDKN
  source: bioentities_symbol
  hgnc_symbol: CDKN1C
  entrez: '1028'
- word: CDKN
  symbol: CDKN
  source: bioentities_symbol
  hgnc_symbol: CDKN2A
  entrez: '1029'
- word: CDKN
  symbol: CDKN
  source: bioentities_symbol
  hgnc_symbol: CDKN2B
  entrez: '1030'
- word: CDKN
  symbol: CDKN
  source: bioentities_symbol
  hgnc_symbol: CDKN2C
  entrez: '1031'
- word: CDKN
  symbol: CDKN
  source: bioentities_symbol
  hgnc_symbol: CDKN3
  entrez: '1033'
- word: CXCR4,
  symbol: CXCR4
  source: hgnc_symbol
  hgnc_symbol: CXCR4
  entrez: '7852'
chemicals:
- word: CAF
  source: MESH
  identifier: C035000
diseases:
- word: Metastatic carcinoma
  source: MESH
  identifier: C538445
- word: growth arrest
  source: MESH
  identifier: D006323
figid_alias: PMC7457231__F6
redirect_from: /figures/PMC7457231__F6
figtype: Figure
---
